High Tower Advisors, LLC Adverum Biotechnologies, Inc. Transaction History

High Tower Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$3.36 - $10.56 $68,040 - $213,840	-20,250 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$9.26 - $14.36 $4,630 - $7,180	-500 Reduced 2.41%	20,250 $201,000
Q4 2020 Feb 10, 2021	BUY	$9.84 - $14.26 $7,626 - $11,051	775 Added 3.88%	20,750 $225,000
Q3 2020 Nov 13, 2020	BUY	$10.3 - $21.64 $205,742 - $432,259	19,975 New	19,975 $207,000
Q2 2020 Aug 10, 2020	SELL	$8.53 - $25.64 $93,830 - $282,040	-11,000 Closed	0 $0
Q1 2020 May 21, 2020	BUY	$7.98 - $16.32 $87,780 - $179,520	11,000 New	11,000 $108,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.